相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diaminodiacid-based solid-phase synthesis of all-hydrocarbon stapled α-helical peptides
Feng-Liang Wang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells
Nam-Hee Kim et al.
PLOS ONE (2015)
Symptoms of endocrine treatment and outcome in the BIG 1-98 study
J. Huober et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Hydrocarbon-Stapled Peptides: Principles, Practice, and Progress
Loren D. Walensky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions
Tetsuro Yoshimaru et al.
SCIENTIFIC REPORTS (2014)
Specific Adverse Events Predict Survival Benefit in Patients Treated With Tamoxifen or Aromatase Inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial Analysis
Duveken B. Y. Fontein et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Targeting BIG3-PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
Tetsuro Yoshimaru et al.
NATURE COMMUNICATIONS (2013)
Aromatase, aromatase inhibitors, and breast cancer
Saranya Chumsri et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
New Strategies in Estrogen Receptor-Positive Breast Cancer
Stephen R. D. Johnston
CLINICAL CANCER RESEARCH (2010)
Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer
Rowan Chlebowski et al.
BREAST (2009)
Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer
Jung-Won Kim et al.
CANCER SCIENCE (2009)
Menopausal symptoms and adjuvant therapy-associated adverse events
P. Hadji
ENDOCRINE-RELATED CANCER (2008)
Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study
B Fisher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Aromatase inhibitors: Future directions
CK Osborne et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Tamoxifen: A most unlikely pioneering medicine
VC Jordan
NATURE REVIEWS DRUG DISCOVERY (2003)
Thermodynamics of the coil-α-helix transition of amphipathic peptides in a membrane environment:: the role of vesicle curvature
T Wieprecht et al.
BIOPHYSICAL CHEMISTRY (2002)
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial
B Fisher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Analysis of estrogen receptor interaction with a repressor of estrogen receptor activity (REA) and the regulation of estrogen receptor transcriptional activity by REA
R Delage-Mourroux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
